Reaction Details | |||
---|---|---|---|
![]() | Report a problem with these data | ||
Target | Phospholipase A2 | ||
Ligand | BDBM47026 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Dose response counterscreen of uHTS hits for ATG4B inhibitors in a Phospholipase A2 assay | ||
IC50 | 2040±n/a nM | ||
Citation | ![]() | ||
More Info.: | Get all data from this article, Assay Method | ||
Phospholipase A2 | |||
Name: | Phospholipase A2 | ||
Synonyms: | Group IB phospholipase A2 | PA21B_HUMAN | PLA2 | PLA2A | PLA2G1B | PPLA2 | Phosphatidylcholine 2-acylhydrolase 1B | Phospholipase A2 (PLA2) | Phospholipase A2 group 1B | phospholipase A2 precursor | ||
Type: | Protein | ||
Mol. Mass.: | 16364.13 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P04054 | ||
Residue: | 148 | ||
Sequence: |
| ||
BDBM47026 | |||
n/a | |||
Name | BDBM47026 | ||
Synonyms: | (Z)-2-methyl-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3-oxidanylidene-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-2-enoic acid | (Z)-2-methyl-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-heptenoic acid | (Z)-2-methyl-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-2-enoic acid | (Z)-6-[(5R,10S,13R,14R,17R)-3-keto-4,4,10,13,14-pentamethyl-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-hept-2-enoic acid | MLS000563429 | SMR000232277 | cid_15944767 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H46O3 | ||
Mol. Mass. | 454.6844 | ||
SMILES | CC(CC\C=C(\C)C(O)=O)[C@H]1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]1(C)CCC(=O)C(C)(C)[C@@H]1CC3 |c:15| | ||
Structure | ![]() |